Teva to buy Allergan's generics business for $40.5B By: CNBC.com News July 27, 2015 at 07:38 AM EDT Israel's Teva Pharmaceutical will buy Allergan's generic pharmaceuticals business for $40.5 billion. Read More >> Related Stocks: Allergan Plc Mylan Teva Pharmaceutical Industries ADR